JP2006523214A - タマンダリン類似物およびこれらのフラグメントそして製造方法および使用方法 - Google Patents

タマンダリン類似物およびこれらのフラグメントそして製造方法および使用方法 Download PDF

Info

Publication number
JP2006523214A
JP2006523214A JP2006507309A JP2006507309A JP2006523214A JP 2006523214 A JP2006523214 A JP 2006523214A JP 2006507309 A JP2006507309 A JP 2006507309A JP 2006507309 A JP2006507309 A JP 2006507309A JP 2006523214 A JP2006523214 A JP 2006523214A
Authority
JP
Japan
Prior art keywords
compound
mmol
methyl
compound according
side chain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006507309A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006523214A5 (https=
Inventor
ジユーリー，マデレーン・エム
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of JP2006523214A publication Critical patent/JP2006523214A/ja
Publication of JP2006523214A5 publication Critical patent/JP2006523214A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K11/00—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0205—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0808—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Transplantation (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2006507309A 2003-03-21 2004-03-19 タマンダリン類似物およびこれらのフラグメントそして製造方法および使用方法 Pending JP2006523214A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45696703P 2003-03-21 2003-03-21
PCT/US2004/008275 WO2004084812A2 (en) 2003-03-21 2004-03-19 Tamandarin analogs and fragments thereof and methods of making and using

Publications (2)

Publication Number Publication Date
JP2006523214A true JP2006523214A (ja) 2006-10-12
JP2006523214A5 JP2006523214A5 (https=) 2007-05-10

Family

ID=33098178

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006507309A Pending JP2006523214A (ja) 2003-03-21 2004-03-19 タマンダリン類似物およびこれらのフラグメントそして製造方法および使用方法

Country Status (8)

Country Link
US (1) US8030279B2 (https=)
EP (1) EP1613338A4 (https=)
JP (1) JP2006523214A (https=)
CN (1) CN1819837A (https=)
AU (1) AU2004224418A1 (https=)
CA (1) CA2519234A1 (https=)
MX (1) MXPA05010064A (https=)
WO (1) WO2004084812A2 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008266282A (ja) * 2007-03-26 2008-11-06 Tama Tlo Kk 制癌剤の有効成分としての環状デプシペプチドおよび当該環状デプシペプチドを有効成分として含有する制癌剤。

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1423564A (zh) * 1999-11-15 2003-06-11 法马马有限公司 癌症的aplidine治疗
US6509315B1 (en) 2000-04-07 2003-01-21 The Trustees Of The University Of Pennsylvania Didemnin analogs and fragments and methods of making and using them
ES2272462T3 (es) * 2000-04-07 2007-05-01 The Trustees Of The University Of Pennsylvania Analogos de tamadarina y didemnina y procedimiento de fabricacion y uso.
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
AU2006253007B2 (en) 2005-05-31 2012-12-20 Alimentary Health Ltd Feline probiotic Bifidobacteria
ATE512211T1 (de) 2005-05-31 2011-06-15 Iams Company Feline probiotische lactobacilli
EP1942193A4 (en) 2005-08-25 2010-10-27 Ube Industries METHOD FOR THE PRODUCTION OF OPTICALLY ACTIVE (S OR R) -AMINOIC ACID OR AN OPTICALLY ACTIVE (S OR R) -α-AMINO-ACID ESTER
CN101389347B (zh) 2006-02-28 2013-03-27 法马马有限公司 提高的抗肿瘤治疗
EP2124966B1 (en) 2007-02-01 2015-09-09 IAMS Europe B.V. Method for decreasing inflammation and stress in a mammal using glucose antimetabolites, avocado or avocado extracts
AU2008313627A1 (en) * 2007-10-19 2009-04-23 Pharma Mar, S.A. Improved antitumoral treatments
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
WO2011020913A2 (en) 2009-08-21 2011-02-24 Pharma Mar, S.A. Cyclodepsipeptide antiviral compounds
CN104003908B (zh) * 2014-01-17 2016-08-17 宁波北仑大港科技创新服务中心 一种保护羟基的丝氨酸的制备方法
HRP20231233T1 (hr) 2017-04-27 2024-01-19 Pharma Mar, S.A. Antitumorski spojevi
CA3169544A1 (en) 2020-03-02 2021-09-10 Pablo Aviles Marin Compounds for use in inflammatory conditions
US20230158104A1 (en) 2020-03-02 2023-05-25 Pharma Mar, S.A. Compounds for use in autoimmune conditions
WO2021175826A1 (en) 2020-03-02 2021-09-10 Pharma Mar, S.A. Compounds for use in the treatment of coronavirus infection
US12168640B2 (en) 2021-11-16 2024-12-17 ProDeg, LLC USP9X inhibitors
EP4433462A4 (en) * 2021-11-16 2025-07-16 Prodeg Llc USP9X INHIBITORS
WO2024165764A1 (en) 2023-02-10 2024-08-15 Pharma Mar, S.A. Plitidepsin for use in the treatment of non-integrated dna viral infections

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4160452A (en) * 1977-04-07 1979-07-10 Alza Corporation Osmotic system having laminated wall comprising semipermeable lamina and microporous lamina
US4256108A (en) * 1977-04-07 1981-03-17 Alza Corporation Microporous-semipermeable laminated osmotic system
US4265874A (en) * 1980-04-25 1981-05-05 Alza Corporation Method of delivering drug with aid of effervescent activity generated in environment of use
US4782135A (en) 1980-09-12 1988-11-01 Board Of Trustees, University Of Illinois Composition of matter and process
US4493796A (en) 1980-09-12 1985-01-15 Board Of Trustees, Univ. Of Ill. Didemnins A, B, C, and derivatives thereof, as antiviral agents
US5137870A (en) 1980-09-12 1992-08-11 The Board Of Trustees Of The University Of Illinois Didemnins and nordidemnins
DE4120327A1 (de) 1991-06-20 1992-12-24 Basf Ag Neue peptide, ihre herstellung und verwendung
ES2102322B1 (es) 1995-07-13 1998-03-01 Pharma Mar Sa Procedimiento de preparacion de didemnina a.
DE69735583T2 (de) 1996-10-24 2007-04-05 The Board Of Trustees Of The University Of Illinois, Urbana Semisynthetisches verfahren zur herstellung von didemninanalogen
PT956033E (pt) 1996-10-24 2003-10-31 Univ Illinois SíNTESE TOTAL DE ANALOGOS AMINO HIP DE DIDEMNINA A
US6509315B1 (en) * 2000-04-07 2003-01-21 The Trustees Of The University Of Pennsylvania Didemnin analogs and fragments and methods of making and using them
ES2272462T3 (es) * 2000-04-07 2007-05-01 The Trustees Of The University Of Pennsylvania Analogos de tamadarina y didemnina y procedimiento de fabricacion y uso.
UA76718C2 (uk) 2000-06-30 2006-09-15 Фарма Мар, С.А. Протипухлинні похідні аплідину
SE523235C2 (sv) * 2003-02-21 2004-04-06 Water Treat Construction I Mot Metod och anordning för att avskilja miljöfarliga ämnen ur en förorenad massa

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
JPN6009066212, Ｊ． Ｐｅｐｔ． Ｒｅｓ．, 199908, Ｖｏｌ．５４， Ｎｏ．２, ｐｐ．１４６−１６１ *
JPN6009066214, Ｔｅｔｒａｈｅｄｒｏｎ, 19990108, Ｖｏｌ．５５， Ｎｏ．２, ｐｐ．３１３−３３４ *
JPN6009066216, Ｊ． Ｏｒｇ． Ｃｈｅｍ．, 20000728, Ｖｏｌ．６５， Ｎｏ．１５, ｐｐ．４７６２−４７６５ *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008266282A (ja) * 2007-03-26 2008-11-06 Tama Tlo Kk 制癌剤の有効成分としての環状デプシペプチドおよび当該環状デプシペプチドを有効成分として含有する制癌剤。

Also Published As

Publication number Publication date
MXPA05010064A (es) 2006-05-17
US20070149446A1 (en) 2007-06-28
AU2004224418A1 (en) 2004-10-07
EP1613338A2 (en) 2006-01-11
WO2004084812A3 (en) 2005-10-06
CN1819837A (zh) 2006-08-16
CA2519234A1 (en) 2004-10-07
EP1613338A4 (en) 2009-06-24
US8030279B2 (en) 2011-10-04
WO2004084812A2 (en) 2004-10-07

Similar Documents

Publication Publication Date Title
JP2006523214A (ja) タマンダリン類似物およびこれらのフラグメントそして製造方法および使用方法
RU2323000C2 (ru) Аналоги тамандарина и дидемнина и способы их получения и применения
RU2135515C1 (ru) Карбаматы и карбамиды, индуцирующие производство цитокинов
ES2272763T3 (es) Derivados de dolastatina 10.
US6509315B1 (en) Didemnin analogs and fragments and methods of making and using them
KR20110111321A (ko) Ｃ형 간염을 예방하거나 치료하기 위한 사이클로스포린 유사체
US11142546B2 (en) Neuropeptide S receptor (NPSR) agonists
US20040097413A1 (en) Synthetic methods for aplidine and new antitumoral derivatives, methods of making and using them
CA3018344C (en) Neuropeptide s receptor (npsr) agonists
RU2299887C2 (ru) Способы синтеза аплидина и новых противоопухолевых производных, способы их промышленного получения и применения
AU2006252266A1 (en) Tamandarin and didemnin analogs and methods of making and using them
AU2017377671A1 (en) Novel compounds as anti-mycobacterials
HK1191034A1 (en) N-carboxyalkyl-auristatins and use thereof

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20070306

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20070306

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20090116

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20090116

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20091222

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20100323

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20100330

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20100831